It was then mechanistically investigated the relevance of SEMA4D in myeloma cells by knock down experiments (42); notably, SEMA4D expression was found to mediate paracrine signaling preventing the induction of the pivotal differentiation factor Runx2 in osteoprogenitor cells. This evidence concerns the gene SEMA4D and plasma cell myeloma.